Showing results (361-370 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 31, 2022
Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosisRuth Ann Marrie, Casandra Dolovich, Gary R Cutter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 30, 2021
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosisHilde Norborg, Trond Riise, Kjell-Morten Myhr, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 2, 2021
Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issueRicardo Alonso, Liliana Patrucco, Berenice Silva, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 25, 2020
Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa regionZhila Maghbooli, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 28, 2020
Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) regionBassem I Yamout, Wassim Assaad, Hani Tamim, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 5, 2019
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis - a pilot trialC Storm-Larsen, K-M Myhr, E Farbu, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 25, 2020
Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS studyOscar Fernández, Guillermo Izquierdo, Eduardo Aguera, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 19, 2021
Expanded access to multiple sclerosis teleneurology care following the COVID-19 pandemicMarisa P McGinley, Shauna Gales, William Rowles, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 15, 2021
EMDR treatment for anxiety in MS patients: A pilot studyOlga C Wallis, Jolanda de Vries
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2021
Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insightsMarc Bigaud, Bettina Rudolph, Emmanuelle Briard, et al.
Pageof 61